PROM Detail

Home PROM Detail
Outcome Rating Scale
  • Basic Information
  • Detailed Information
  • Domains
  • Psychometrics

Basic Information

Abbreviated name
ORS
Full name
Outcome Rating Scale
Items ?
The number of questions in the survey
4
Short description
A simple, four-item session by session measure designed to assess areas of life functioning known to change as a result of therapeutic intervention.
PCCC or QoL? ?
This compendium contains patient-reported measures that are either designed to specifically measure aspects of Person Centred Co-Ordinated Care (P3C), or alternatively tools that are designed to measure some aspect of Quality of Life (QoL) or Health Related Quality of Life (hrQoL). All the measures in this compendium have been broadly categorised into one of those two concepts.
Person Centred Coordinated Care
Main Domains Measured ?
This is the key domains that the measure is targeting.
Patient functionality (interpersonally, individually, socially and overall wellbeing)
Type of measure ?
The measures in this compendium can take a variety of forms. Generally, they will be either Patient Reported Outcome Measure (PROM) or Patient Reported Experience Measure (PREM). However, we have also included a few measures that are completed by proxy-individual (PROXY), which are useful in instances where the respondent cannot answer directly (e.g. dementia or end of life). Sometimes, these measures can even be a composite of these types, and target both experiences and outcomes – we have labelled these measures “PROEMs”.
PROM
Respondent ?
The person that fills in the questionnaire - e.g. patient, Health Care Professional, or proxy (normally a carer or family member)
Patients
Permissive licence ?
Whether the measure is free to use without major restrictions, or instead permission and/or licensing fees are required. E.g. if "Yes", you should seek authorisation/permission prior to using the instrument.
A license to use the ORS is available for free to
Licence link ?
A link to the vendor/supplier for licensing of the measure
http://scott-d-miller-ph-d.myshopify.com/collections/performance-metrics/products/performance-metrics-licenses-for-the-ors-and-srs
Copy of questionnaire
http://scott-d-miller-ph-d.myshopify.com/collections/performance-metrics/products/performance-metrics-licenses-for-the-ors-and-srs

Detailed Information

Year developed ?
The year in which the measure was first published.
2000
Country developed in ?
The main country[s] in which the measure was first developed.
US
Website link ?
A link to the developer of the measure, if they have a website.
http://scottdmiller.com/wp-content/uploads/documents/OutcomeRatingScale-JBTv2n2.pdf and link to full article http://www.sciencedirect.com/science/article/pii/S109830151504930X
Target condition ?
The measures can be either generic or disease specific (e.g. Diabetes, Heart Failure)
Mental Health
Main context tested in ?
The main context in which the measure has been developed and used (E.g. Hopital, General Practice etc).
Mental Health Therapy
Main countries used in ?
The main countries in which the measure has been developed and used.
US, The Netherlands
Target age ?
e.g. Adults, Children, Elderly
Adolescents and adults
Main uses of measure ?
The context in which the measure is most often used – e.g. clinical trials; national surveys.
Measuring patient functionality throughout the course of treatment.
Used in UK? ?
Whether the instrument has been tested and validated within a UK healthcare context.
No
Language
English
Other versions available
CORS (child version) and YCORS (young child version) available.
Flesch-Kincaid readability tests ?
A rating that corresponds approximately to US school grade level. For example, a score of 8.0 means that an eighth grader can understand the document. Generally, a score of 7 or 8 should be appropriate.
3.5

Domains

Domain description
Patient functionality (interpersonally, individually, socially and overall wellbeing)

Psychometrics

Brief description ?
A brief description of the initially reported psychometric properties of the measure.
The coefficient alpha ranged from .87 at the first administration to .96 at the third and fourth administration. Coefficient alpha for all administrations (N = 336) was .93 (Miller & Duncan, 2003).